Skip to content

Ultrasound neck and thyroid

Thyroid, cervical nodal levels, salivary glands as indicated

When to use it

  • Thyroid nodule characterisation and risk stratification.
  • Neck lump, cervical lymphadenopathy.

Technique

  • High-frequency linear transducer, typically in the 7-15 MHz range; a lower-frequency curvilinear or small-footprint probe is added for a large goitre or to reach behind the clavicle.
  • Patient supine with the neck extended over a pillow or pad placed under the shoulders — the extension is what brings the lower poles and the isthmus out from behind the sternum, and a study done with the head flat is the usual reason a lower pole is called "not seen".
  • Both lobes and the isthmus swept in transverse and longitudinal planes; each lobe measured in three dimensions and each reported nodule measured in three dimensions, since the maximum diameter drives the size threshold for biopsy.
  • Each nodule characterised against the features the risk-stratification systems use: composition, echogenicity, shape (taller-than-wide on the transverse image), margin, and echogenic foci — ACR TI-RADS in North America, and British Thyroid Association U-classification or EU-TIRADS elsewhere. State which system was applied, because the biopsy thresholds are not interchangeable.
  • Cervical nodal levels are surveyed in the same sitting where the question is malignancy or a neck lump, with attention to levels III, IV and VI for thyroid primaries; loss of the fatty hilum, rounded shape, cystic change and punctate calcification are the abnormal features.
  • Colour Doppler for vascularity, and a swallow manoeuvre where retrosternal extension or a mobile mass is in question.

Where it goes wrong

  • Ultrasound cannot assess retrosternal extension or deep spaces — a substernal goitre needs cross-sectional imaging.

Clinical questions that reach this study

Contrast

None

Acquisition